Introduction
Extrarenal RNA virus infections can trigger de novo immune complex glomerulonephritis, e.g. hepatitis C virus-associated glomerulonephritis, but more frequently RNA viruses trigger disease activity of preexisting glomerular inflammation, like in IgA nephropathy, lupus nephritis or renal vasculitis [1] . Viral infection activates systemic antiviral immune responses that may trigger disease flares of glomerulonephritis by enhancing autoantibody production, immune complex formation or by systemic interferon (IFN) release [2] . Induction of type I IFN is a central element of antiviral immunity because type I IFNs inhibit viral replication in the infected cells and have pleiotrophic immunomodulatory effects [3] . In the intravascular compartment, plasmacytoid dendritic cells (pDC) are the main type I IFN-producing cell type [2] . Single-and double-stranded RNA activate type I IFN production only after being taken up into intracellular endosomes where they activate TLR3 (dsRNA) or TLR7/8 (ssRNA) [4, 5] . Furthermore, viral RNA entering the intracellular cytosol of pDCs triggers type I IFN production via two helicases, i.e. melanoma-differentiation-associated gene (MDA)-5 (dsRNA) and retinoic-acid-inducible protein (RIG)-1 (5 -triphosphate RNA) [6] [7] [8] [9] [10] .
Despite the obvious clinical association of viral infection and glomerulonephritis, it is unknown whether renal cells produce type I IFN in glomerulonephritis. We recently observed that viral dsRNA can activate murine mesangial cells to produce large amounts of IFN-α and IFN-β when the RNA reaches the intracellular cytosol where it activates TLR-independent RNA recognition pathway [(Flür, et al., under revision) ]. Most remarkably, the type I IFN dsRNA activates glomerular endothelial cells 3313 activated mesangial cells in an autocrine-paracrine activation loop and was necessary for mounting significant IL-6 release or for triggering mesangial cells apoptosis, a finding previously thought to exclusively enhance the activation of pDCs and B cells [11, 12] . Intrigued by these findings, we hypothesized that viral dsRNA may have similar functions in glomerular endothelial cells (GEnC). Several studies have reported that viral dsRNA can activate other endothelia but the literature is controversial on the induction of type I interferon release [13] [14] [15] . GEnC represent the intravascular component of the glomerular filtration barrier and therefore first interact with circulating viral particles in the glomerulus [16, 17] . GEnC have the potential to promote glomerular inflammation by secreting proinflammatory cytokines and by enhancing local leukocyte recruitment via presenting chemokines and adhesion molecules at the luminal GEnC membrane [18] . Yet it remains unclear whether GEnC contribute to viral recognition via innate pattern recognition receptors. GEnC express a distinct pattern of TLRs, i.e. TLR1-6 [19] ; thus, they cannot recognize viral U-rich ssRNA, the natural ligand of TLR7/8 [20, 21] . But whether GEnC express any of the aforementioned cytosolic RNA sensors and whether viral dsRNA can trigger type I interferons in GEnC are unknown. We hypothesized that GEnC harbour TLR-independent cytosolic RNA recognition pathways and that viral dsRNA can trigger antiviral immunity and inflammation in GEnC.
Material and methods

GEnC culture and biochemicals
GEnC, prepared from ts A58 immorto mice [22] , were grown in medium RPMI 1640 (Invitrogen, Paisley, UK) with 10% heat-inactivated fetal calf serum (FCS). GEnC were stimulated with endotoxin-free poly I:C RNA (Invivogen, Toulouse, France) either pure or complexed with the cationic lipid (CL) lipofectamine 2000 (Invitrogen) for 24 h in a medium containing 2% FCS. Poly I:C RNA and CL were preincubated with polymyxin B (Invivogen) before use to block any residual LPS contamination. Murine IFN-α was purchased from Serotec (Oxford, UK), IFN-β from PBL (Piscataway, NJ, USA), IFN-γ from PeproTech (Rocky Hill, NJ, USA), chloroquine and methyl-β-cyclodextrin from Sigma-Aldrich (Steinheim, Germany), chlorpromazine from Merck (Darmstadt, Germany), cytochalasin D from BIOMOL (Plymouth Meeting, PA, USA), MyD88 homodimerization inhibitory peptide or control peptide from Imgenex (San Diego, CA, USA) and Pam3CSK (P 3 C) from Invitrogen. Rat monoclonal antibodies against mouse IFN-α and IFN-β (PBL) were used to neutralize these IFNs in vitro. Cytokine levels were measured in cell supernatants using commercial ELISA kits for IL-6 (OptEiA, BD, Mannheim Germany), IFN-α (PBL), IFN-β (PBL), IFN-γ (BD), CCL2/MCP-1 (BD), CCL5/RANTES and CXCL10/IP-10 (R&D Systems, Minneapolis, MN, USA). GEnC proliferation was determined after 72 h using CellTiter 96 R Aqueous One Solution Cell Proliferation Assay (Promega, Madison, WI, USA) reading absorbance at 492 nm.
Real-time PCR and reverse transcription
Complementary DNA was generated from total RNA using random priming and MMLV reverse transcriptase (Invitrogen). Real-time PCR was performed using SYBRGreen PCR Master Mix or on Roche Light Cycler 480 (Roche Diagnostics, Mannheim, Germany). All values were normalized to 18s rRNA. The oligonucleotide primer sequences are listed in Table 1 .
Immunoblotting. GEnC were washed and lysed in a lysis buffer (1% Triton, 10 mM Tris, 10 mM NaCl, 10 mM EDTA, 10 µg/ml aprotinin, 10 µg/ml leupeptin and 1mM phenylmethylsulfonylfluoride, pH 7.4). Total In vitro fluorescein-albumin permeability assay. GEnC were grown to confluent monolayers hanging on a 1 µm pore size polyethylene terephthalate membrane of Millicell Hanging Cell Culture Insert obtained from Millipore, Billerica, MA, in 24-well plates with 0.5 ml media on both sides [19, 23] . Then, 160 µg/ml FITC-labelled bovine serum albumin (Invitrogen) was added to inserts and the cells were stimulated with either CL alone, 3 µg/ml poly I:C RNA/CL or 6 µg/ml CpG-DNA, the latter TLR9 agonist being used as a negative (nucleic acid) control in this assay. The filtrate was sampled at different time points and OD was measured at 485 nm and emission at 535 nm.
RNA silencing studies. RIG-1 (DDX58) and MDA5 siRNA ONTARGETplus SMART pool oligonucleotides (Dharmacon, Lafayette, CO, USA) and negative control siRNA (Ambion/Applied Biosystems, Darmstadt, Germany) sequences were as follows: DDX58 5 -CAAGAA GAGUACCACUUAAUU-3 , 5 -GUUAGAGGAACACAGAUUAUU-3 , 5 -GUUCGAGAUUCCAGUCAUAUU-3 , 5 -GAAGAGCACGAGAUA GCAAUU-3 ; Mda5, 5 -GAACGUAGACGACAUAUUA-3 , 5 -CA ACGAAGCCCUACAAAUC-3 , 5 -CUUGAUGCCUUUACCAUUA-3 , 5 -GGGAGAUUGUUAAUGAUUU-3 . A total of 1 × 10 5 GEnC were plated in 12-well plates in 2% FCS-RPMI medium; 40 nM siRNA was transfected twice with CL as above. Twenty-four hours later, GEnC were stimulated with 10 µg of poly I:C RNA/CL. The knock-down efficacy of RIG-1 and MDA5 as well as CXCL10 mRNA expression was determined by real-time RT-PCR after 6 h.
Statistical analysis
Data were expressed as mean ± standard error of the mean (SEM). A comparison between groups was performed by two-tailed t-test or oneway ANOVA. A value of P < 0.05 was considered to be statistically significant.
Results
Complexed poly I:C RNA activates GEnC to secrete type I interferons
TLR3 is the only nucleic acid-specific TLR expressed by GEnC [19] . Usually, 10-100 µg/ml of poly I:C RNA is required to activate TLR in murine and human endothelial cells [24] [25] [26] [27] [28] , but much lower poly I:C RNA concentrations can activate cytosolic helicases in dendritic cells when they reach the intracellular cytosol, e.g. when being complexed with cationic lipids (CL) [8] . Low concentrations of poly I:C RNA/CL complexes activated GEnC to secrete IL-6 < CCL2/MCP-1 < CCL5/RANTES < CXCL10/IP-10 as well as IFN-α and IFN-β ( Figure 1 ) but not IFN-γ (not shown) in a dose-dependent manner. The induction of IL-6, CCL5/RANTES and CXCL10/IP-10 by poly I:C RNA/CL was more potent as compared to 6 µg/ml LPS, a potent EC activator. Poly I:C RNA stimulation depended on the presence of CL that on its own had no effect on GEnC cytokine release. Thus, poly I:C RNA is a potent activator of GEnC cytokine, chemokine and type I (but not type II) IFN secretion when being complexed with CL.
GENC activation by poly I:C RNA requires intracellular uptake via a clathrin-dependent endocytotic pathway but is independent of TLR signalling
In dendritic cells and embryonic fibroblasts, the dsRNA-CL complex needs to reach the cytosol before it can interact with its putative cytosolic RNA receptor [8, 29, 30] . To identify the possible intracellular uptake mechanism, we stimulated GEnC with poly I:C RNA/CL in the presence or absence of chlorpromazine, known to specifically block clathrin-dependent endocytosis [31, 32] , methyl-β cyclodextrin blocking caveolae-dependent endocytosis [33] and cytochalasin D blocking phagocytosis, respectively. The poly I:C RNA-induced production of CXCL10/IP-10 was inhibited by chlorpromazine but not by any of the other compounds (Figure 2A ), suggesting clathrin-dependent endocytosis of poly I:C RNA. Does GEnC activation involve TLR signalling? Most TLRs signal via the intracellular adaptor MyD88 but poly I:C RNA/CL did not involve MyD88 signalling because it was not affected by 100 µM of a MyD88 inhibiting peptide that prevented GEnC CCL2 production induced by the TLR2/MyD88 pathway agonist Pam3Cys ( Figure 2B) . One of the poly I:C RNA receptors Poly I:C RNA activate GEnC to produce multiple proinflammatory mediators. GEnC were exposed to increasing doses of pI:C RNA complexed or not complexed with CL as indicated (doses are given in unit µg/ml). Exposure to CL, CpG-DNA or LPS was used as controls. Supernatants were harvested after 24 h and the concentrations of various cytokines, chemokines and interferons were determined by ELISA. Data are means ± SEM from three experiments each analysed in duplicates. * P < 0.05 versus medium.
is TLR3 that activates the adaptor TRIF from intracellular endosomes. Chloroquine blocks endosomal acidification and poly I:C RNA-mediated TLR3 activation [32] but it did not affect poly I:C RNA/CL-mediated activation of GEnC (Figure 2A ). Together, clathrin-dependent endocytosis contributes to poly I:C RNA uptake into GEnC. In addition, RNA-induced GEnC activation is not affected by inhibition of MyD88 or endosomal TLR3/TRIF signalling. 
GEnC express the viral dsRNA recognition receptors TLR3, MDA5 and RIG-1
Which of the innate dsRNA recognition receptors are expressed in GEnC? The mRNA expression levels of TLR3, RIG-1 and MDA-5 were low under basal culture conditions but rapidly increased upon IFN-β stimulation ( Figure 3A) . The immediate IFN-β-induced expression of receptor mRNAs mostly returned to baseline levels at 12 h ( Figure 3A) . Immunoblotting of GEnC protein extracts taken after 24h of stimulation confirmed that IFN-β induced the expression of TLR3, RIG-1 and MDA5, although this was most evident at higher doses of IFN-β ( Figure 3B ). Together, IFN-β induces TLR3, MDA5 and RIG-1 mRNA and protein in GEnC.
Poly I:C RNA/CL complexes activate GEnC via RIG-1 not MDA5
RIG-1 and MDA5 are cytosolic sensors of poly I:C RNA/CL complexes but their individual role differs in different cell types [8] . We used specific small inhibitory (s.i.) RNAs to suppress either RIG-1 or MDA5 expression in GEnC ( Figure 4A and B) . RIG-1 knockdown reduced IL-6 and IFN-β mRNA expression after poly I:C RNA/CL complex exposure that was not seen when an unspecific control RNA was used ( Figure 4A ). In contrast, MDA5 knockdown did not affect poly I:C RNA/CL complex-induced IL-6 and 5 . Type I interferon-blocking antibodies do not affect GEnC activation. GEnC were exposed to 3 µg/ml pI:C RNA and increasing doses of neutralizing antibodies against IFN-α and IFN-β were added. After 24-h cell culture, supernatants were harvested and CXCL10/IP10 concentrations were determined by ELISA. Data represent means ± SEM.
IFN-β mRNA levels in GEnC ( Figure 4B ). We therefore conclude that poly I:C RNA/CL complexes activate GEnC via RIG-1, not via MDA5.
Poly I:C RNA does not act in a type I IFN-dependent autocrine-paracrine activation loop
In dendritic cells, the recognition of viral dsRNA induces the release of type I IFN that enhance subsequent TLR signalling via autocrine-paracrine recognition of type I IFN involving the IFNAR and STAT1 phosphorylation [11] . We have recently shown that poly I:C RNA triggers this autoactivation loop in mesangial cells; hence, we hypothesized the same for GEnC. To examine whether type I IFN produced by the GEnC contributes to dsRNA-induced secretion of CXCL10/IP-10 in an autocrine-paracrine manner, we stimulated GEnC with poly I:C RNA in the absence or presence of increasing doses of antibodies that neutralize the functions of IFN-α and IFN-β. By blocking both type I IFN, the poly I:C RNA-induced CXCL10/IP-10 production of GEnC remained unaffected ( Figure 5 ). Thus, cytosolic dsRNA signalling activates GEnC to secrete type I IFN but this does not contribute to GENC activation in the autocrine-paracrine activation loop.
Poly I:C RNA induces ICAM-1 and VCAM-1 surface expression in GEnC
EC activation can induce luminal expression of adhesion molecules that enhance leukocyte extravasation into extravascular compartments [18] . We used flow cytometry for ICAM-1 and VCAM-1 to test whether poly I:C RNA induces GEnC adhesion molecule expression. The basal expression of ICAM-1 was much less on GEnC as compared to that of VCAM-1 ( Figure 6 ). Twenty-four hours after exposure to these nucleic acids, GEnC revealed a significant increase of the percentage of GEnC with ICAM-1 surface expression ( Figure 6 ). The effect of dsRNA on VCAM-1 surface expression was poor and statistically significant at the highest RNA concentration. The stimulatory effect depended on complex formation with CL. However, the induction of both ICAM-1 and VCAM-1 remained much lower as compared to the induction seen with LPS stimulation ( Figure 6 ). Together, GEnC activation upon poly I:C RNA exposure includes increased surface expression of ICAM-1.
Poly I:C RNA increases albumin flux through GEnC monolayers
GEnC contribute to the glomerular filtration barrier, and systemic exposure to poly I:C RNA increases proteinuria in nephritic mice [34] . To test whether poly I:C RNA/CL directly affects albumin flux through GEnC, GEnC monolayers were cultured in well inserts and 160 µg/ml FITClabelled BSA was added to the upper well. BSA concentrations in the lower well were determined after 6, 24 and 48 h by reading OD at 535 nm. Complexed poly I:C RNA significantly increased GEnC albumin flux at 24 and 48 h as compared to cells cultured in vehicle alone ( Figure 7 ). In contrast, CpG-DNA, an agonist to TLR9 absent on GEnCs, had no effect ( Figure 7) . Hence, poly I:C RNA increases albumin flux through GEnC.
Discussion
GEnC are continously exposed to circulating micro-and macromolecules including viral particles during viral infections. Although, circulating RNA is usually rapidly digested by RNAses, complexed RNA, e.g. in immune complexes, may be protected and elicit immunostimulatory effects [35] [36] [37] . Complexed RNA often deposits along glomerular capillaries in immune complex disease that can activate GEnC [38, 39] . We questioned whether complexed viral dsRNA could activate GEnC via the recently discovered TLR-independent cytosolic RNA recognition pathway [9] that potently activates dendritic cells and embryonic fibroblasts to trigger type I IFN secretion via activating the transcription factor IRF3 [8] . Here we show for the first time that complexed dsRNA activates GEnC to release type I IFN as well as other antiviral defence mechanisms that may enhance glomerular inflammation. High concentrations of extracellular poly I:C RNA are known to activate immune cells as well as EC via TLR3 [4, [24] [25] [26] [27] [28] , but much lower concentrations of complexed poly I:C RNA were sufficient to activate GEnC secretion of multiple proinflammatory cytokines, chemokines and type I IFN. Complex formation with CL facilitates the intracellular uptake of the nucleic acids into cells. In GEnC, this process involved clathrin-dependent endocytosis, a mechanism recently shown to mediate the intracellular uptake of dsRNA in Drosophila melanogaster S2 cells [31] or of poly I:C RNA into human embryonic kidney 293 cells [32] . The role of endosomal (Toll-like) receptors, of which GEnC express only the dsRNA-specific TLR3 [19] , could be excluded by our experiments using the endosomal acidification inhibitor chloroquine and the phagocytosis inhibitor cytochalasin D. Peptide MyD88 inhibition did also not affect GEnC activation by dsRNA RNA ruling out the contribution of other TLR or of members of the IL-1 receptor family. Finally, our s.i.RNA experiments confirmed that complexed poly I:C RNA activates GEnC via RIG-1 and not via MDA5 that is in contrast to observations made in mouse embryonic fibroblasts or dendritic cells [8] . However, poly I:C RNA recognition in human keratinocytes is mediated via RIG-1 and MDA5 [40] while human mesothelial cells require only RIG-1 [41] . Thus, the preferred cytosolic dsRNA sensor may differ between different cell types and was identified to be RIG-1 in murine GEnC.
We have recently shown that mesangial cells produce large amounts of type I IFN in response to cytosolic poly I:C RNA. Blocking the secreted IFN with neutralizing IFN-α and IFN-β antibodies revealed that the type I IFN produced activates mesangial cell cytokine and chemokine production in an autocrine-paracrine activation loop. We hypothesized a similar role of type I IFN release in GenC, but we found that identical doses of neutralizing IFN-α and IFN-β antibodies did not affect poly-I:C RNA-induced CXCL10 release in GEnC. Local type I IFN release can trigger multiple immunoregulatory functions and antiviral effectors [2, 42] . For example, type I IFN-dependent genes activate the antiviral endoribonuclease RNAse L, a mechanism that initiates the cleavage of viral RNA [9] and that can produce small self-RNA cleavage products that enhance type I IFN signalling via RIG-1 and MDA5 in a positive amplification loop [43] . Among the proinflammatory chemokines produced by GEnC upon exposure to dsRNA, CXCL10/IP-10 is of particular interest because it is specifically induced by IFN and preferentially recruits cytotoxic T cells via the chemokine receptor CXCR3 [44] . The recruitment of leukocytes to the glomerulus is further supported by the induction of ICAM-1 expression, a surface molecule that mediates the firm adhesion of circulating leukocytes to activated renal endothelia [45] , including GEnC in human postinfectious glomerulonephritis [46] . The coordinated interaction of selectin-dependent leukocyte rolling, chemokine-mediated activation of leukocytic integrins and the subsequent integrin-mediated firm adhesion with the respective adhesion molecules is required to allow the firm leukocyte adhesion to the luminal endothelial cell membrane [47] .
DsRNA also enhanced albumin flux through GEnC monolayers, a potential novel mechanism for viral infection-induced proteinuria that may assist the clearance of viral particles and inflammatory cytokines via urinary excretion. Our observation in GEnC is consistent with the finding that poly I:C RNA can increase the leakage across brain microvascular endothelial cells in vitro and in vivo via an vascular endothelial growth factor-dependent disintegration of tight junctions [26] . Together, when entering the intracellular cytosol, poly I:C RNA stimulates GEnC to produce multiple proinflammatory cytokines and type I IFN via RIG-1. GEnC activation also includes the expression of ICAM-1, increased albumin flux and reduced GEnC proliferation, a novel mechanism that should contribute to glomerulonephritis triggered or aggravated by infection with RNA viruses.
